Loading...

Globus Medical, Inc.

GMED•NYSE
Healthcare
Medical - Devices
$94.87
$0.49(0.52%)
U.S. Market opens in 30h 27m

Globus Medical, Inc. (GMED) Stock Overview

Explore Globus Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap12.8B
P/E Ratio23.88
EPS (TTM)$3.92
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$85.45
3 Months$72.87
1 Year Target$93.06

GMED Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Globus Medical, Inc. (GMED) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $93.06.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.88 and a market capitalization of 12.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.53%
5-Day Change
0.86%
1-Month Change
10.006%
3-Month Change
2.55%
6-Month Change
52.32%
Year-to-Date (YTD) Change
8.67%
1-Year Change
29.85%
3-Year Change
63.33%
5-Year Change
32.70%
All-Time (Max) Change
602.81%

Contact Information

https://www.globusmedical.com
610 930 1800
2560 General Armistead Avenue, Audubon, PA, 19403

Company Facts

5,300 Employees
IPO DateAug 3, 2012
CountryUS
Actively Trading

Frequently Asked Questions